Pharma Capital, Ltd.

Pharma Capital invests directly in drug assets, particularly in preclinical and early clinical stages. The firm employs unique de-risking strategies to optimize investments and mitigate development risks, aiming to avoid costly late-stage failures while addressing high unmet medical needs in biotech and healthcare.

Email Corporate@pharmacapital.co.uk with your deck to pitch Pharma Capital.